These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 6291801)

  • 41. Long-term hemodynamic and clinical efficacy of captopril therapy in ambulatory management of severe chronic congestive heart failure.
    Awan NA; Amsterdam EA; Hermanovich J; Bommer WJ; Needham KE; Mason DT
    Am Heart J; 1982 Apr; 103(4 Pt 1):474-9. PubMed ID: 6801943
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Intravenous captopril in congestive heart failure.
    Ahmad S; Giles TD; Roffidal LE; Haney Y; Given MB; Sander GE
    J Clin Pharmacol; 1990 Jul; 30(7):609-14. PubMed ID: 2202753
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Immediate and sustained hemodynamic and clinical improvement in chronic heart failure by an oral angiotensin-converting enzyme inhibitor.
    Ader R; Chatterjee K; Ports T; Brundage B; Hiramatsu B; Parmley W
    Circulation; 1980 May; 61(5):931-7. PubMed ID: 6244906
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Captopril improves hemodynamic response to static exercise in patients with congestive heart failure: a double-blind, placebo-controlled, randomized trial.
    Borgi C; Magelli C; Costa FV; Magnani B; Ambrosioni E
    Clin Cardiol; 1990 May; 13(5):329-34. PubMed ID: 2189613
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Haemodynamic, neurohumoral and exercise effects of losartan vs. captopril in chronic heart failure: results of an ELITE trial substudy. Evaluation of Losartan in the Elderly.
    Houghton AR; Harrison M; Cowley AJ
    Eur J Heart Fail; 1999 Dec; 1(4):385-93. PubMed ID: 10937952
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The contributions of sympathetic tone and the renin-angiotensin system to severe chronic congestive heart failure: response to specific inhibitors (prazosin and captopril).
    Kluger J; Cody RJ; Laragh JH
    Am J Cardiol; 1982 May; 49(7):1667-74. PubMed ID: 7044087
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Vasodilatation with captopril and prazosin in chronic heart failure: double blind study at rest and on exercise.
    Bayliss J; Canepa-Anson R; Norell MS; Poole-Wilson P; Sutton G
    Br Heart J; 1986 Mar; 55(3):265-73. PubMed ID: 3513808
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Hemodynamic and radionuclide effects of acute captopril therapy for heart failure: changes in left and right ventricular volumes and function at rest and during exercise.
    Massie B; Kramer BL; Topic N; Henderson SG
    Circulation; 1982 Jun; 65(7):1374-81. PubMed ID: 6280890
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Symptomatic hemodynamic and hormonal effects of intravenous captopril in patients with heart failure.
    Wu H; Zhao HY
    Chin Med J (Engl); 1994 May; 107(5):342-6. PubMed ID: 7924573
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A comparison of hemodynamic effects of one-month oral captopril and enoximone treatment for severe congestive heart failure.
    Scriven AJ; Lipkin DP; Anand IS; Sutton GC; Poole-Wilson PA
    Am J Cardiol; 1987 Aug; 60(5):68C-71C. PubMed ID: 2956872
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Impaired skeletal muscle nutritive flow during exercise in patients with congestive heart failure: role of cardiac pump dysfunction as determined by the effect of dobutamine.
    Wilson JR; Martin JL; Ferraro N
    Am J Cardiol; 1984 May; 53(9):1308-15. PubMed ID: 6711433
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A multicenter study of the safety and efficacy of benazepril hydrochloride, a long-acting angiotensin-converting enzyme inhibitor, in patients with chronic congestive heart failure.
    Insel J; Mirvis DM; Boland MJ; Cinquegrani MP; Shanes J; Rubin SA; Whalen JJ
    Clin Pharmacol Ther; 1989 Mar; 45(3):312-20. PubMed ID: 2537699
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Acute regional vascular effects of intravenous captopril in a rat model of myocardial infarction and failure.
    Drexler H; Depenbusch JW; Truog AG; Zelis R; Flaim SF
    J Pharmacol Exp Ther; 1987 Apr; 241(1):13-9. PubMed ID: 3553536
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Angiotensin-converting enzyme inhibitors in preventing remodeling and development of heart failure after acute myocardial infarction: results of the German multicenter study of the effects of captopril on cardiopulmonary exercise parameters (ECCE).
    Kleber FX; Sabin GV; Winter UJ; Reindl I; Beil S; Wenzel M; Fischer M; Doering W
    Am J Cardiol; 1997 Aug; 80(3A):162A-167A. PubMed ID: 9293972
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Hemodynamic patterns of response during long-term captopril therapy for severe chronic heart failure.
    Packer M; Medina N; Yushak M; Meller J
    Circulation; 1983 Oct; 68(4):803-12. PubMed ID: 6352079
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Mixed venous blood temperature response to exercise in heart failure patients treated with short-term vasodilators.
    Shellock FG; Rubin SA
    Clin Physiol; 1985 Dec; 5(6):503-14. PubMed ID: 3912094
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Arterial oxygenation and arterial oxygen transport in chronic myocardial failure at rest, during exercise and after hydralazine treatment.
    Rubin SA; Brown HV; Swan HJ
    Circulation; 1982 Jul; 66(1):143-8. PubMed ID: 7083500
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effects of captopril on the distribution of left ventricular output with ventricular septal defect.
    Boucek MM; Chang RL
    Pediatr Res; 1988 Oct; 24(4):499-503. PubMed ID: 3050850
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Acute hemodynamic effect of oral MDL 17,043 in severe congestive heart failure.
    Uretsky BF; Generalovich T; Reddy PS; Salerni R; Valdes AM; Spangenberg RB; Lang JF; Okerholm RA
    Am J Cardiol; 1984 Aug; 54(3):357-62. PubMed ID: 6235735
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Sympathetic activation on effort in patients with chronic heart failure. Long term effects of captopril.
    Boschetti E; Tantucci C; Cocchieri M; Castellano M; Alunni G; Bruni B; Fortunati F; Grassi V
    Acta Cardiol; 1988; 43(5):569-82. PubMed ID: 3149103
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.